Antihypertensive medication use among US adults with hypertension

Circulation

Volumn 113, Issue 2, 2006, Pages 213-221

  Gu, Qiuping ^a   Paulose Ram, Ryne ^b   Dillon, Charles ^b   Burt, Vicki ^b  

^a National Center for Health Statistics   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

Drugs; Hypertension; Population

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LISINOPRIL; METOPROLOL; NIFEDIPINE; PROPRANOLOL; TRIAMTERENE; VERAPAMIL;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; HEALTH SURVEY; HEART FAILURE; HEART INFARCTION; HISPANIC; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; UNITED STATES; ADOLESCENT; CROSS-SECTIONAL STUDY; MIDDLE AGED; STATISTICAL ANALYSIS; STATISTICS;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; HYPERTENSION; INTERVIEWS; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; UNITED STATES;

EID: 33645000530     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.542290     Document Type: Article

References (27)

1. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:1-7.
2. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2001.
3. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult U.S. population: data from the Health Examination Surveys, 1960 to 1991. Hypertension. 1995;26:60-69.
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, for the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Hypertension. 2003;42:1206-1252.
5. US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd ed. Washington, DC: US Government Printing Office; 2000.
6. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA. 1997;277:739-745.
7. Joint National Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
8. Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995;155:829-837.
9. Siegel D, Lopez J. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? JAMA. 1997;278:1745-1748.
10. Nelson CR, Knapp DA. Trends in antihypertensive drug therapy of ambulatory patients by U.S. office-based physicians. Hypertension. 2000;36:600-603.
11. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Vital Health Stat. 1994;1:1-407.
12. NHANES 1999-2000 public data release file document. Available at: http:/www.cdc.gov/nchs/about/major/nhanes/datalink.htm. Accessed December 27, 2005.
13. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the U.S. adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
14. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
15. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39:920-929.
16. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, Version 6.4. 2nd ed. Research Triangle Park, NC: Research Triangle Institute; 1996.
17. Wolter K. Introduction to Variance Estimation. New York, NY: Springer-Verlag; 2004.
18. Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, Cohen JD, Lacy CR, Perry HM Jr, Blaufox MD, Wassertheil-Smoller S, Black HR, Schron E, Berkson DM, Curb JD, Smith WM, McDonald R, Applegate WB, for the SHEP Cooperative Research Group. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1997;278:212-216.
19. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, Fagard RH. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865-872.
20. Kannel WB. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gend Specif Med. 2002;5:27-37.
21. Moser M. Why are physicians not prescribing diuretics more frequently in the management of hypertension? JAMA. 1998;279:1813-1816.
22. Moser M, Blaufox MD, Freis E, Gifford RW Jr, Kirkendall W, Langford H, Shapiro A, Sheps S. Who really determines your patients' prescriptions? JAMA. 1991;265:498-500.
23. Ubel PA, Jepson C, Asch DA. Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians. J Gen Intern Med. 2003;18:977-983.
24. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427.
25. Moser M. Rationale for combination therapy in the management of hypertension. J Clin Hypertens (Greenwich). 2003;5:17-25.
26. Mehta SS, Wilcox CS, Schulman KA. Treatment of hypertension in patients with comorbidities: results from the Study of Hypertensive Prescribing Practices (SHyPP). Am J Hypertens. 1999;12:333-340.
27. Glover MJ, Greenlund KJ, Ayala C, Croft JB. Racial/ethnic disparities in prevalence, treatment, and control of hypertension: United States, 1999-2002. Morb Mortal Wkly Rep. 2005;54:7-9.